Boston Scientific Corp (BSX) 12.34 $BSX
Market Maker Surveillance Report. BSX, RAD, NIHD, AMD, ALU, ENZR, Highest Net Sell Volume and Negative Price Friction For Tuesday, September 16th 2014
M2 - 1 hr 17 mins ago
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4902 companies with "abnormal" market making, 2597 companies with positive Friction Factors and 2316 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Boston Scientific Corp (NYSE:BSX), Rite Aid Corp (NYSE:RAD), NII Holdings Inc (NASDAQ:NIHD), Advanced Micro Devices Inc (NYSE:AMD), Alcatel Lucent SA (NYSE:ALU), ENERGIZER RESOURCES INC (OTC:ENZR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Boston Scientific Receives CE Mark For The Vercise(TM) Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
PR Newswire - Tue Sep 16, 11:00PM CDT
Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of tremor, including the most common form of this movement disorder known as essential tremor (ET). Tremor is characterized by involuntary and rhythmic shaking, usually associated with difficulty in an activity such as writing or holding and controlling items.
China PTCA Balloon Market Investment Report, 2014-2016
M2 - Tue Sep 16, 6:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m5b5rl/china_ptca) has announced the addition of the "China PTCA Balloon Market Investment Report, 2014-2016" report to their offering. PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI. As national economy develops and people's living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis. Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China's demand for PTCA balloon will hit 1.824 million sets by 2016. At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009. Key Topics Covered: 1. Concepts Related to PTCA Balloon Industry 2. Operating Environment of Chinese PTCA Balloon Market 3. Overview of Chinese PTCA Balloon Market 4. Investment in Chinese PTCA Balloon Market 5. Major Chinese Companies 6. Major Foreign Companies - Abbott - B. Braun Melsungen - Boston Scientific - Dalian Yinyi - Demax Medical (Beijing) - JW Medical - Lepu Medical - Medtronic - MicroPort - Neich Medical (Shenzhen) - SCW Medicath - Sino Medical - Synexmed - Terumo For more information visit http://www.researchandmarkets.com/research/m5b5rl/china_ptca
REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus(TM) Valve System
PR Newswire - Mon Sep 15, 3:05PM CDT
New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus(TM) Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement.
Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org
PRWeb - Mon Sep 15, 2:31PM CDT
"Canada Gynecological Devices Market Outlook to 2020″, provides key market data on the Canada Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings) Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10483 . The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Complete Report Details Available @ http://www.marketoptimizer.org/canada-gynecol...-2020.html . Overview of Key Companies in Canada, Gynecological Devices Market: Conceptus, Inc. Hologic, Inc. CooperSurgical, Inc. Cook Group Incorporated Utah Medical Products, Inc. Boston Scientific Corporation Johnson & Johnson Merit Medical Systems, Inc. BSD Medical Corporation Scope Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Gynecological Devices market. Global corporate-level profiles of key companies operating within the Gynecological Devices market. Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Inquire before Buying @ http://www.marketoptimizer.org/contacts/inqui...name=10483 . (This is a premium report priced at US$2500 for a single user License.)
3 Reasons Edwards Lifesciences Corp.'s Stock Could Fall
Dan Carroll, The Motley Fool - Motley Fool - Mon Sep 15, 1:48PM CDT
Edwards Lifesciences has pulled off a remarkable turnaround in 2014. This stock, crushed by the market throughout late 2012 and 2013, has gone on a tear so far this year. Edwards' shares have surprised Wall Street with a 53% year-to-date climb,...
North America Non-Vascular Stents Market Outlook to 2020
M2 - Mon Sep 15, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4sd4sm/north_america) has announced the addition of the "North America Non-Vascular Stents Market Outlook to 2020" report to their offering. "North America Non-Vascular Stents Market Outlook to 2020", provides key market data on the North America Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate Stents (Metal, Polymer and Bioabsorbable Prostate Stents) and Urethral Stents (Metal, Polymer and Bioabsorbable Urethral Stents)). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Non-Vascular Stents market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Non-Vascular Stents market. - Global corporate-level profiles of key companies operating within the Non-Vascular Stents market. - Key players covered include Boston Scientific, Taewoong Medical, Merit Medical, Cook Medical, PNN Medical, Teleflex, Inc. and C.R. Bard. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Non-Vascular Stents Market, North America 4 Non-Vascular Stents Market, Canada 5 Non-Vascular Stents Market, Mexico 6 Non-Vascular Stents Market, United States 7 Overview of Key Companies in North America Non-Vascular Stents Market 8 Appendix Companies Mentioned - Boston Scientific Corporation - Cook Group Incorporated - C. R. Bard, Inc. - Covidien plc - Taewoong Medical Co.,Ltd. - Applied Medical Corporation - Olympus Corporation - ConMed Corporation For more information visit http://www.researchandmarkets.com/research/4s...th_america
Boston Scientific (BSX) Approaches New Downside Target of $12.38
Comtex SmarTrend(R) - Mon Sep 15, 9:02AM CDT
Shares of Boston Scientific (NYSE:BSX) have bearishly opened below the pivot of $12.51 today and have reached the first support level of $12.44. Analysts will be watching for a cross of the next downside pivot targets of $12.38 and $12.25.
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
Market Activity, Upcoming Conference, Dividend, and New Agreement - Research Reports on Express Scripts, Boston Scientific, Zimmer, Medivation and Aetna
PR Newswire - Fri Sep 12, 8:15AM CDT
Today, Analysts Review released its research reports regarding Express Scripts Holding Company (NASDAQ: ESRX), Boston Scientific Corporation (NYSE: BSX), Zimmer Holdings, Inc. (NYSE: ZMH), Medivation Inc. (NASDAQ: MDVN) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6428-100free.
Global Laparoscopy Devices Industry Report 2014
M2 - Fri Sep 12, 6:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qcv7mj/global) has announced the addition of the "Global Laparoscopy Devices Industry Report 2014" report to their offering. The Global Laparoscopy Devices Industry Report 2014 is a professional and in-depth study on the current state of the global laparoscopic devices. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The laparoscopic devices market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Laparoscopic devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on eighteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Key Topics Covered: Chapter One Laparoscopy Devices Industry Overview Chapter Two Global Laparoscopy Devices Market Status Analysis Chapter Three Major Regions Laparoscopy Devices Market Status Analysis Chapter Four Major Countries Laparoscopy Devices Market Status and Analysis Chapter Five Major Companies Laparoscopy Devices Market Status and Analysis Chapter Six Laparoscopy Devices Industry Chain and Marketing Channels Analysis Chapter Seven Laparoscopy Devices Industry Segment Market Analysis Chapter Eight Laparoscopy Devices Industry Development Trend Chapter Nine Laparoscopy Devices New Project Investment Feasibility Analysis Chapter Ten Global Laparoscopy Devices Industry Research Conclusions Companies Mentioned: - Boston Scientific - COOK MEDICAL - Covidien - Ethicon Endo-Surgery - Fujifilm - HAWK - KARL STORZ - Kangji - OLYMPUS - OPTCAL - PAJUNK - RICHARD WOLF - SHENDA - SHIKONGHOU - SMITH & NEPHEW - Stryker - Tonglu - Tonglu Yida For more information visit http://www.researchandmarkets.com/research/qcv7mj/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The Market for Neurotechnology: 2014-2018 - Technology, Markets, Competitors and Growth Rates in Four Key Segments
M2 - Fri Sep 12, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lwdj78/the_market_for) has announced the addition of the "The Market for Neurotechnology: 2014-2018" report to their offering. This newly published market research report is the most comprehensive and up-to-date publication available covering the neurotechnology industry. The report takes an in-depth look at the technology, markets, competitors, and growth rates in four key segments of the neurotechnology industry in the years 2014 through 2018. It forecasts the number of systems to be sold, worldwide revenue, compound annual growth rates, and competitor market shares for several key product categories making up the neural prostheses, neuromodulation, neurorehabilitation, and neurosensing segments of the industry. The Market for Neurotechnology: 2014-2018 covers in detail all the key public companies and the most significant emerging and more established non-public firms in the industry. The report also features in-depth profiles of major research institutions in the U.S. and abroad involved with neurotechnology developments, and traces the commercial activity that is emerging from each. The report not only looks at future financial projections, it covers likely technology trends and product developments that will impact the neurotechnology industry in the years ahead, such as: - Nanowire brain implants guided into position through the cerebral vasculature. - Optical stimulation devices that solve many of the problems associated with electrical charge buildup. - Microfluidic interfaces that combine electrical stimulation and drug delivery. The Market for Neurotechnology: 2014-2018 examines each of the neurological diseases and disorders that represent a significant market potential for neurotechnology products, including established markets like Parkinson's disease, chronic pain, and urinary incontinence, as well as emerging markets such as tinnitus, vestibular disorders, obesity, migraine, sleep disorders, and affective disorders. And it is the only report on the neurotechnology industry to forecast new product categories in neurorehabilitation and neurosensing such as brain analysis systems and neurorobotic systems. Key Topics Covered: 1. Introduction 2. Industry Background 3. Neurotechnology Markets 4. Product Categories 5. Company Profiles 6. Market Activity 7. Research Institutions 8. Funding Sources 9. Future Directions 10. Company Listings Companies Mentioned - Advanced Bionics - Boston Scientific - CVRx - Cochlear Ltd. - Cyberonics - Medtronic - Natus Medical - Nevro Corp. - Several Others - Spinal Modulation - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/lw...market_for
Market Maker Surveillance Report. BSX, SMA, EMC, BX, GCVRZ, PFMT, Bullishly Biased Price Friction For Thursday, September 11th 2014
M2 - Fri Sep 12, 4:16AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4878 companies with "abnormal" market making, 2401 companies with positive Friction Factors and 2459 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Boston Scientific Corp (NYSE:BSX), Symmetry Medical Inc (NYSE:SMA), EMC Corp (NYSE:EMC), BIOX Corp (NYSE:BX), Sanofi SA (NASDAQ:GCVRZ), (NYSE
FMT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Dallas Jury Awards Transvaginal Mesh Patient $73 Million in Boston Scientific Lawsuit, Baron and Budd Reports
Business Wire - Thu Sep 11, 5:10PM CDT
Earlier this week, a Dallas jury returned a $73 million verdict in favor of a woman who has suffered serious health problems after being implanted with Boston Scientific's Obtryx transvaginal mesh product. Baron and Budd congratulates Matthews & Associates, Freese and Goss, Edwards & de la Cerda and the rest of the trial team on their victory. The firm hopes that this verdict helps to pave the way for positive results in other transvaginal mesh lawsuits. Baron and Budd represents hundreds of women harmed by transvaginal mesh implants.
Texas Jury awards $73 Million in Pelvic Mesh Case, announces Matthews & Associates
PR Newswire - Wed Sep 10, 3:58PM CDT
A 12-person jury on Monday ordered Boston Scientific Corp. to pay a Texas woman $73 million after finding the company negligent in both the design and marketing of its Obtryx transvaginal mesh sling.
Watch for Boston Scientific to Potentially Pullback After Gaining 1.05% Yesterday
Comtex SmarTrend(R) - Wed Sep 10, 3:56PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.35 to a high of $12.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $12.45 on volume of 20.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 1.05% Rise
Comtex SmarTrend(R) - Wed Sep 10, 3:56PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.35 to a high of $12.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $12.45 on volume of 20.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
pSivida Corp. Names James Barry to Board of Directors
Business Wire - Wed Sep 10, 3:00PM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that it has elected James J. Barry, Ph.D. to its Board of Directors.
Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014
PR Newswire - Wed Sep 10, 8:00AM CDT
Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for life and to developing innovative therapies in interventional cardiology. The company will share results from more than a dozen clinical studies at the 26th Transcatheter Cardiovascular Therapeutics (TCT) meeting, the annual scientific symposium of the Cardiovascular Research Foundation, being held this year in Washington, D.C. from September 13-17.
Market Maker Surveillance Report. WEN, BSX, MO, BA, MSFT, ORCL, Highest Net Buy Volume With Lowest Price Friction For Tuesday, September 9th 2014
M2 - Wed Sep 10, 3:39AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4670 companies with "abnormal" market making, 1404 companies with positive Friction Factors and 3746 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Tuesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Wendy's Company (NASDAQ:WEN), Boston Scientific Corp (NYSE:BSX), Altria Group Inc (NYSE:MO), Boeing Co (NYSE:BA), MICROSOFT CORPORATION (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Surveillance Report. BSX, RAD, NIHD, AMD, ALU, ENZR, Highest Net Sell Volume and Negative Price Friction For Tuesday, September 16th 2014
M2 - 1 hr 17 mins ago
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4902 companies with "abnormal" market making, 2597 companies with positive Friction Factors and 2316 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Boston Scientific Corp (NYSE:BSX), Rite Aid Corp (NYSE:RAD), NII Holdings Inc (NASDAQ:NIHD), Advanced Micro Devices Inc (NYSE:AMD), Alcatel Lucent SA (NYSE:ALU), ENERGIZER RESOURCES INC (OTC:ENZR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Boston Scientific Receives CE Mark For The Vercise(TM) Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
PR Newswire - Tue Sep 16, 11:00PM CDT
Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of tremor, including the most common form of this movement disorder known as essential tremor (ET). Tremor is characterized by involuntary and rhythmic shaking, usually associated with difficulty in an activity such as writing or holding and controlling items.
China PTCA Balloon Market Investment Report, 2014-2016
M2 - Tue Sep 16, 6:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m5b5rl/china_ptca) has announced the addition of the "China PTCA Balloon Market Investment Report, 2014-2016" report to their offering. PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI. As national economy develops and people's living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis. Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China's demand for PTCA balloon will hit 1.824 million sets by 2016. At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009. Key Topics Covered: 1. Concepts Related to PTCA Balloon Industry 2. Operating Environment of Chinese PTCA Balloon Market 3. Overview of Chinese PTCA Balloon Market 4. Investment in Chinese PTCA Balloon Market 5. Major Chinese Companies 6. Major Foreign Companies - Abbott - B. Braun Melsungen - Boston Scientific - Dalian Yinyi - Demax Medical (Beijing) - JW Medical - Lepu Medical - Medtronic - MicroPort - Neich Medical (Shenzhen) - SCW Medicath - Sino Medical - Synexmed - Terumo For more information visit http://www.researchandmarkets.com/research/m5b5rl/china_ptca
REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus(TM) Valve System
PR Newswire - Mon Sep 15, 3:05PM CDT
New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus(TM) Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement.
Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org
PRWeb - Mon Sep 15, 2:31PM CDT
"Canada Gynecological Devices Market Outlook to 2020″, provides key market data on the Canada Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings) Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10483 . The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Complete Report Details Available @ http://www.marketoptimizer.org/canada-gynecol...-2020.html . Overview of Key Companies in Canada, Gynecological Devices Market: Conceptus, Inc. Hologic, Inc. CooperSurgical, Inc. Cook Group Incorporated Utah Medical Products, Inc. Boston Scientific Corporation Johnson & Johnson Merit Medical Systems, Inc. BSD Medical Corporation Scope Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Gynecological Devices market. Global corporate-level profiles of key companies operating within the Gynecological Devices market. Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Inquire before Buying @ http://www.marketoptimizer.org/contacts/inqui...name=10483 . (This is a premium report priced at US$2500 for a single user License.)
3 Reasons Edwards Lifesciences Corp.'s Stock Could Fall
Dan Carroll, The Motley Fool - Motley Fool - Mon Sep 15, 1:48PM CDT
Edwards Lifesciences has pulled off a remarkable turnaround in 2014. This stock, crushed by the market throughout late 2012 and 2013, has gone on a tear so far this year. Edwards' shares have surprised Wall Street with a 53% year-to-date climb,...
North America Non-Vascular Stents Market Outlook to 2020
M2 - Mon Sep 15, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4sd4sm/north_america) has announced the addition of the "North America Non-Vascular Stents Market Outlook to 2020" report to their offering. "North America Non-Vascular Stents Market Outlook to 2020", provides key market data on the North America Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate Stents (Metal, Polymer and Bioabsorbable Prostate Stents) and Urethral Stents (Metal, Polymer and Bioabsorbable Urethral Stents)). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Non-Vascular Stents market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Non-Vascular Stents market. - Global corporate-level profiles of key companies operating within the Non-Vascular Stents market. - Key players covered include Boston Scientific, Taewoong Medical, Merit Medical, Cook Medical, PNN Medical, Teleflex, Inc. and C.R. Bard. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Non-Vascular Stents Market, North America 4 Non-Vascular Stents Market, Canada 5 Non-Vascular Stents Market, Mexico 6 Non-Vascular Stents Market, United States 7 Overview of Key Companies in North America Non-Vascular Stents Market 8 Appendix Companies Mentioned - Boston Scientific Corporation - Cook Group Incorporated - C. R. Bard, Inc. - Covidien plc - Taewoong Medical Co.,Ltd. - Applied Medical Corporation - Olympus Corporation - ConMed Corporation For more information visit http://www.researchandmarkets.com/research/4s...th_america
Boston Scientific (BSX) Approaches New Downside Target of $12.38
Comtex SmarTrend(R) - Mon Sep 15, 9:02AM CDT
Shares of Boston Scientific (NYSE:BSX) have bearishly opened below the pivot of $12.51 today and have reached the first support level of $12.44. Analysts will be watching for a cross of the next downside pivot targets of $12.38 and $12.25.
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
Market Activity, Upcoming Conference, Dividend, and New Agreement - Research Reports on Express Scripts, Boston Scientific, Zimmer, Medivation and Aetna
PR Newswire - Fri Sep 12, 8:15AM CDT
Today, Analysts Review released its research reports regarding Express Scripts Holding Company (NASDAQ: ESRX), Boston Scientific Corporation (NYSE: BSX), Zimmer Holdings, Inc. (NYSE: ZMH), Medivation Inc. (NASDAQ: MDVN) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6428-100free.
Global Laparoscopy Devices Industry Report 2014
M2 - Fri Sep 12, 6:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qcv7mj/global) has announced the addition of the "Global Laparoscopy Devices Industry Report 2014" report to their offering. The Global Laparoscopy Devices Industry Report 2014 is a professional and in-depth study on the current state of the global laparoscopic devices. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The laparoscopic devices market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Laparoscopic devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on eighteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Key Topics Covered: Chapter One Laparoscopy Devices Industry Overview Chapter Two Global Laparoscopy Devices Market Status Analysis Chapter Three Major Regions Laparoscopy Devices Market Status Analysis Chapter Four Major Countries Laparoscopy Devices Market Status and Analysis Chapter Five Major Companies Laparoscopy Devices Market Status and Analysis Chapter Six Laparoscopy Devices Industry Chain and Marketing Channels Analysis Chapter Seven Laparoscopy Devices Industry Segment Market Analysis Chapter Eight Laparoscopy Devices Industry Development Trend Chapter Nine Laparoscopy Devices New Project Investment Feasibility Analysis Chapter Ten Global Laparoscopy Devices Industry Research Conclusions Companies Mentioned: - Boston Scientific - COOK MEDICAL - Covidien - Ethicon Endo-Surgery - Fujifilm - HAWK - KARL STORZ - Kangji - OLYMPUS - OPTCAL - PAJUNK - RICHARD WOLF - SHENDA - SHIKONGHOU - SMITH & NEPHEW - Stryker - Tonglu - Tonglu Yida For more information visit http://www.researchandmarkets.com/research/qcv7mj/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The Market for Neurotechnology: 2014-2018 - Technology, Markets, Competitors and Growth Rates in Four Key Segments
M2 - Fri Sep 12, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lwdj78/the_market_for) has announced the addition of the "The Market for Neurotechnology: 2014-2018" report to their offering. This newly published market research report is the most comprehensive and up-to-date publication available covering the neurotechnology industry. The report takes an in-depth look at the technology, markets, competitors, and growth rates in four key segments of the neurotechnology industry in the years 2014 through 2018. It forecasts the number of systems to be sold, worldwide revenue, compound annual growth rates, and competitor market shares for several key product categories making up the neural prostheses, neuromodulation, neurorehabilitation, and neurosensing segments of the industry. The Market for Neurotechnology: 2014-2018 covers in detail all the key public companies and the most significant emerging and more established non-public firms in the industry. The report also features in-depth profiles of major research institutions in the U.S. and abroad involved with neurotechnology developments, and traces the commercial activity that is emerging from each. The report not only looks at future financial projections, it covers likely technology trends and product developments that will impact the neurotechnology industry in the years ahead, such as: - Nanowire brain implants guided into position through the cerebral vasculature. - Optical stimulation devices that solve many of the problems associated with electrical charge buildup. - Microfluidic interfaces that combine electrical stimulation and drug delivery. The Market for Neurotechnology: 2014-2018 examines each of the neurological diseases and disorders that represent a significant market potential for neurotechnology products, including established markets like Parkinson's disease, chronic pain, and urinary incontinence, as well as emerging markets such as tinnitus, vestibular disorders, obesity, migraine, sleep disorders, and affective disorders. And it is the only report on the neurotechnology industry to forecast new product categories in neurorehabilitation and neurosensing such as brain analysis systems and neurorobotic systems. Key Topics Covered: 1. Introduction 2. Industry Background 3. Neurotechnology Markets 4. Product Categories 5. Company Profiles 6. Market Activity 7. Research Institutions 8. Funding Sources 9. Future Directions 10. Company Listings Companies Mentioned - Advanced Bionics - Boston Scientific - CVRx - Cochlear Ltd. - Cyberonics - Medtronic - Natus Medical - Nevro Corp. - Several Others - Spinal Modulation - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/lw...market_for
Market Maker Surveillance Report. BSX, SMA, EMC, BX, GCVRZ, PFMT, Bullishly Biased Price Friction For Thursday, September 11th 2014
M2 - Fri Sep 12, 4:16AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4878 companies with "abnormal" market making, 2401 companies with positive Friction Factors and 2459 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Boston Scientific Corp (NYSE:BSX), Symmetry Medical Inc (NYSE:SMA), EMC Corp (NYSE:EMC), BIOX Corp (NYSE:BX), Sanofi SA (NASDAQ:GCVRZ), (NYSE
FMT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . Dallas Jury Awards Transvaginal Mesh Patient $73 Million in Boston Scientific Lawsuit, Baron and Budd Reports
Business Wire - Thu Sep 11, 5:10PM CDT
Earlier this week, a Dallas jury returned a $73 million verdict in favor of a woman who has suffered serious health problems after being implanted with Boston Scientific's Obtryx transvaginal mesh product. Baron and Budd congratulates Matthews & Associates, Freese and Goss, Edwards & de la Cerda and the rest of the trial team on their victory. The firm hopes that this verdict helps to pave the way for positive results in other transvaginal mesh lawsuits. Baron and Budd represents hundreds of women harmed by transvaginal mesh implants.
Texas Jury awards $73 Million in Pelvic Mesh Case, announces Matthews & Associates
PR Newswire - Wed Sep 10, 3:58PM CDT
A 12-person jury on Monday ordered Boston Scientific Corp. to pay a Texas woman $73 million after finding the company negligent in both the design and marketing of its Obtryx transvaginal mesh sling.
Watch for Boston Scientific to Potentially Pullback After Gaining 1.05% Yesterday
Comtex SmarTrend(R) - Wed Sep 10, 3:56PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.35 to a high of $12.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $12.45 on volume of 20.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 1.05% Rise
Comtex SmarTrend(R) - Wed Sep 10, 3:56PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.35 to a high of $12.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $12.45 on volume of 20.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
pSivida Corp. Names James Barry to Board of Directors
Business Wire - Wed Sep 10, 3:00PM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that it has elected James J. Barry, Ph.D. to its Board of Directors.
Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014
PR Newswire - Wed Sep 10, 8:00AM CDT
Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for life and to developing innovative therapies in interventional cardiology. The company will share results from more than a dozen clinical studies at the 26th Transcatheter Cardiovascular Therapeutics (TCT) meeting, the annual scientific symposium of the Cardiovascular Research Foundation, being held this year in Washington, D.C. from September 13-17.
Market Maker Surveillance Report. WEN, BSX, MO, BA, MSFT, ORCL, Highest Net Buy Volume With Lowest Price Friction For Tuesday, September 9th 2014
M2 - Wed Sep 10, 3:39AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4670 companies with "abnormal" market making, 1404 companies with positive Friction Factors and 3746 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Tuesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Wendy's Company (NASDAQ:WEN), Boston Scientific Corp (NYSE:BSX), Altria Group Inc (NYSE:MO), Boeing Co (NYSE:BA), MICROSOFT CORPORATION (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
